|
Volumn 146, Issue 6, 2002, Pages 743-749
|
The addition of ribavirin to interferon-α therapy in patients with hepatitis C virus-related chronic hepatitis does not modify the thyroid autoantibody pattern but increases the risk of developing hypothyroidism
a a a a a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ALPHA INTERFERON;
ANTIVIRUS AGENT;
LEVOTHYROXINE;
LIOTHYRONINE;
RIBAVIRIN;
THYROGLOBULIN ANTIBODY;
THYROID ANTIBODY;
THYROID HORMONE;
THYROID PEROXIDASE;
THYROTROPIN;
THYROXINE;
ADULT;
AGED;
ANTIBODY BLOOD LEVEL;
ARTICLE;
AUTOIMMUNE DISEASE;
CHRONIC HEPATITIS;
CONTROLLED STUDY;
CORRELATION ANALYSIS;
DRUG EFFICACY;
DRUG POTENTIATION;
FEMALE;
HEPATITIS C;
HEPATITIS C VIRUS;
HUMAN;
HYPOTHYROIDISM;
MAJOR CLINICAL STUDY;
MALE;
PRIORITY JOURNAL;
REMISSION;
RISK ASSESSMENT;
THYROID DISEASE;
THYROID FUNCTION;
THYROID HORMONE BLOOD LEVEL;
|
EID: 0036299570
PISSN: 08044643
EISSN: None
Source Type: Journal
DOI: 10.1530/eje.0.1460743 Document Type: Article |
Times cited : (78)
|
References (38)
|